Pharmaids Pharmaceuticals
60.98
+1.01(+1.68%)
Market Cap₹215.10 Cr
PE Ratio-
IndustryHealthcare
Company Performance:
1D+1.68%
1M-2.28%
6M-10.09%
1Y+56.64%
5Y+785.05%
View Company Insightsright
More news about Pharmaids Pharmaceuticals
25Jul 25
Shankarappa Nagaraja Vinaya Babu Launches Open Offer for 26% Stake in Pharmaids Pharmaceuticals at ₹62.15 Per Share
Shankarappa Nagaraja Vinaya Babu and Tumkur Trade Center Private Limited have announced an open offer to acquire up to 26% stake in Pharmaids Pharmaceuticals at ₹62.15 per share, valuing the deal at ₹56.99 crore. The offer period is from August 4 to August 18, 2025. The acquirers currently hold a combined 24.36% stake, which could increase to 51.28% post-offer. Most existing promoters will seek reclassification as public shareholders, while the acquirers will become new promoters. Pharmaids Pharmaceuticals, engaged in pharmaceutical and biotechnology services, reported a revenue of ₹1,944.74 lakh and a net loss of ₹1,350.51 lakh for FY ending March 31, 2025.
Pharmaids Pharmaceuticals
60.98
+1.01
(+1.68%)
1 Year Returns:+56.64%
Industry Peers
Sun Pharmaceutical
1,586.70
(-2.50%)
Divis Laboratories
5,689.50
(-3.52%)
Cipla
1,499.40
(-0.68%)
Torrent Pharmaceuticals
3,561.00
(+0.83%)
Dr Reddys Laboratories
1,253.10
(-1.73%)
Mankind Pharma
2,482.90
(-1.71%)
Zydus Life Science
975.00
(-4.34%)
Lupin
1,919.80
(-2.23%)
Alkem Laboratories
5,433.00
(-1.36%)
Aurobindo Pharma
1,090.00
(-0.64%)